title: Brimonidine tartrate 0.33% gel for the management of posttreatment erythema induced by laser skin resurfacing.
authors.affiliation: Department of Dermatology, Heinrich-Heine University, Düsseldorf, Germany.
authors.forename: Stephan Alexander
authors.initials: SA
authors.lastname: Braun
authors.affiliation: Department of Dermatology, Sourasky Medical Center, Tel Aviv, Israel.
authors.forename: Ofir
authors.initials: O
authors.lastname: Artzi
authors.affiliation: Department of Dermatology, Heinrich-Heine University, Düsseldorf, Germany. Electronic address: peterarne.gerber@med.uni-duesseldorf.de.
authors.forename: Peter Arne
authors.initials: PA
authors.lastname: Gerber
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000008:administration & dosage*; D000328:Adult; D000068438:Brimonidine Tartrate / Q000008:administration & dosage*; D003357:Cosmetic Techniques / Q000009:adverse effects*; D004890:Erythema / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D005782:Gels; D006801:Humans; D053685:Laser Therapy / Q000009:adverse effects*
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D005782:Gels; D000068438:Brimonidine Tartrate
keywords: carbon-dioxide; erbium:yttrium-aluminium-garnet; fractional ablative lasers; management; side effects; therapy